SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Impact of birth HIV PCR testing on routine 6-week EID testing in Cape Town, South Africa | Dr. L. DunningView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Does HIV DNA-PCR testing of HIV-exposed infants at birth reduce follow-up for routine testing at 4-14 weeks of age? | Dr. E. KalkView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Decreased bone turnover in HIV-infected children on antiretroviral therapy | Dr. S. ShiauView Slideset
AJAli JuddPhDSlidesetHIVInternational Workshop on HIV & Pediatrics 2016High-Resource Perspective on Adolescent Transition and Research Priorities | Ali JuddView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Higher retention and viral suppression rates in dedicated adolescent-friendly HIV clinic in South Africa | Brian Zanoni, MD, MPHView Slideset
RFRashida FerrandFRCP, PhD, FMed SciSlidesetHIVInternational Workshop on HIV & Pediatrics 2016It’s Not Just HIV: Complications and Research Priorities in Care of HIV-Infected Youth | Rashida Ferrand, MBBS, MRCP, MSc, DRM&HView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016The global epidemiology of perinatally HIV-infected adolescents: A CIPHER Global Cohort Collaboration analysis | Dr. Amy SlogroveView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Low-Resource Perspective on Adolescent Transition and Research Priorities | Mary-Ann Davies, MBChB, MMed, PhD, FCView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Paediatric HIV point of care testing: field evaluation of the performance of Cepheid and Alere qualitative HIV assays in a Soweto academic hospital | Dr. T. MurrayView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Switching to second-line antiretroviral therapy in HIV-infected children: a CIPHER cohort collaboration global analysis | Dr. R. GoodallView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016HIV PCR testing at birth in KwaZulu Natal, South Africa – one year post introduction of the largest neonatal HIV testing programme | Dr. F. MoyoView Slideset
SlidesetHIVInternational Workshop on HIV & Pediatrics 2016Raltegravir (RAL) pharmacokinetics (PK) and safety in HIV-1-exposed neonates at high risk of infection (IMPAACT 1110) | Dr. D. ClarkeView Slideset
